Tian He

Zhongshan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Association Between Preoperative Albumin Supplementation and Postoperative Outcomes in Hypoalbuminemia Patients After Hepatocellular Carcinoma Hepatectomy: REAL Study.

Association Between Preoperative Albumin Supplementation and Postoperative Outcomes in Hypoalbuminemia Patients After Hepatocellular Carcinoma Hepatectomy: REAL Study.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: February 23, 2026

Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy.

Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy.

Journal: Hepatology (Baltimore, Md.)

Published: September 04, 2025

Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy.

Deep learning-assisted tumor radiomic dynamics on MRI predict pathological complete response in HCC undergoing immune-based therapy followed by hepatectomy.

Journal: Hepatology (Baltimore, Md.)

Published: September 04, 2025

Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular Carcinoma.

Stable Disease without Tumor Shrink Cannot Benefit from Surgery following Immune-Based Therapy in Potentially Resectable Hepatocellular Carcinoma.

Journal: Liver cancer

Published: August 14, 2025

CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance.

CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: February 17, 2025

Computational framework for prioritizing candidate compounds overcoming the resistance of pancancer immunotherapy.

Computational framework for prioritizing candidate compounds overcoming the resistance of pancancer immunotherapy.

Journal: Cell reports. Medicine

Published: December 15, 2024

Evidence summary of nursing care of arterial drug administration and catheter management for HAIC in hepatocellular carcinoma.

Evidence summary of nursing care of arterial drug administration and catheter management for HAIC in hepatocellular carcinoma.

Journal: Medicine

Published: December 06, 2024

Enhanced antitumor efficacy of STING agonist MSA-2 by lipid nanoparticles delivering circular IL-23 mRNA and platinum-modified MSA-2 combination.

Enhanced antitumor efficacy of STING agonist MSA-2 by lipid nanoparticles delivering circular IL-23 mRNA and platinum-modified MSA-2 combination.

Journal: Materials today. Bio

Published: November 13, 2024

Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation.

Targeting tumor-intrinsic BCL9 reverses immunotherapy resistance by eliciting macrophage-mediated phagocytosis and antigen presentation.

Journal: Nature communications

Published: October 24, 2024

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy.

The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy.

Journal: Biomarker research

Published: July 03, 2024

Reproductive safety of STING agonists MSA-2 and manganese-MSA-2.

Reproductive safety of STING agonists MSA-2 and manganese-MSA-2.

Journal: Toxicology research

Published: May 21, 2024

Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus Immunotherapy.

Depth of Radiographic Response as an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy following Targeted Therapy plus Immunotherapy.

Journal: Liver cancer

Published: April 08, 2024

Showing 1-12 of 13

Last Updated: 09/26/2026